CV DEATH HAS A NEW OPPONENT
CV DEATH HAS A NEW OPPONENT

Empagliflozin JARDIANCE improves QoL of HF patients

Document ID: PC-PH-104584

27/03/2023

Author: Boehringer Ingelheim

Related content

 
PC-PH-104584
Production date: March 2023